Losartan-hctz 50-12.5 MG tab 1000S
Ended Awarded Last action
- Contract number
- SPE2DR26FR0KA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,305
Award facts
- Contract value 100% obligated
- $25,304.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,304.85 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (1,000 count) on January 7, 2026, with completion expected by January 8, 2026. This award was made on a firm fixed-price basis without any set-aside designation, indicating open competition. The contractor, headquartered in Conshohocken, Pennsylvania, is the child entity of parent company Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal government healthcare systems. This delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to military healthcare programs worldwide.
The IDC encompasses a broad range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related supplies across multiple therapeutic domains. Through this vehicle, AmerisourceBergen provides critical pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's federal contract portfolio demonstrates significant capability in fulfilling diverse medical supply requirements, with awards ranging from small transactions to substantial orders, establishing AmerisourceBergen as a key vendor in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FR0KA?
SPE2DR26FR0KA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FR0KA worth?
The government has obligated $25,305 on SPE2DR26FR0KA.
Is contract SPE2DR26FR0KA an order under another contract?
Yes. SPE2DR26FR0KA is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0KA competed?
The extent of competition for SPE2DR26FR0KA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award